Next Article in Journal
Concordance Rate of Colposcopy in Detecting Cervical Intraepithelial Lesions
Next Article in Special Issue
Automated Detection of Cervical Carotid Artery Calcifications in Cone Beam Computed Tomographic Images Using Deep Convolutional Neural Networks
Previous Article in Journal
Is Omalizumab Related to Ear and Labyrinth Disorders? A Disproportionality Analysis Based on a Global Pharmacovigilance Database
 
 
Review
Peer-Review Record

The Potential Role of Artificial Intelligence in Lung Cancer Screening Using Low-Dose Computed Tomography

Diagnostics 2022, 12(10), 2435; https://doi.org/10.3390/diagnostics12102435
by Philippe A. Grenier 1,*, Anne Laure Brun 2 and François Mellot 2
Reviewer 1:
Reviewer 2: Anonymous
Diagnostics 2022, 12(10), 2435; https://doi.org/10.3390/diagnostics12102435
Submission received: 13 September 2022 / Revised: 4 October 2022 / Accepted: 6 October 2022 / Published: 8 October 2022

Round 1

Reviewer 1 Report

Grenier et al reviewed the potential applications of Artificial Intelligence in lung cancer screening with low dose CT. In particular they assessed the role of AI in management of lung nodules and smoking-related diseases on LDCT scans in LCS.

Despite its essentially narrative structure, the paper is well written, comprehensive and timely.

Minor flaws

Some editing for typing errors is necessary (line 17, line 66, line 118, line 258, line 260, line 323, line 347).

Line 191. To label smoking related findings in subjects undergoing LCS as “incidental” findings reflects the american coarse lexicon. Actually, they should be more appropriately defined as “collateral” findings, given that they are certainly expected, leaving the term incidental to those findings which are unrelated to smoking history, e.g. thyroid cancer, timoma, etc.

It should be noted that in the Pinsky’s et al. recent study, emphysema was simply considered as present or absent by collecting the many radiologists reading of thousands LDCTs in NLST and that no quantification of emphysema was done. The study essentially provides a very rough estimation of the predicitive value of emphysema in LCS screenes, leaving room for more exhaustive quantitative assessment, likely supported by AI.

Author Response

Point1 

Some editing for typing errors are necessary

Response

 Line 17: a comma was added after "scans"

Line 66: ever-smokers was replaced by smokers

Line 118: the short trait (-) was deleted

Line 258: the strikethrough word "model" was deleted

Line 260: the strikethrough word "when" was deleted

Line: 323: "simultaneously" was replaced by "simultaneous"

Line 347: ?

Point 2

Line 19: to label smoking related findings in subjects undergoing LCS as "incidental findings" reflects american coarse lexicon. Actually, they should be more appropriately defined as "collateral findings"....

Response

"incidental" was replaced by "collateral"

Point 3

It should be noted that in the Pinsky's et al. recent study, emphysema was simply considered as absent or present by collecting the many radiologists reading of thousands LDCTs in NLST and that no quantification of emphysema was done......

Response

The sentence "Hence, Pinsky et al. who evaluated in the NLST data the association between incidental respiratory findings on LDCT scans with increased respiratory disease mortality, found emphysema on LDCT images was associated with a significant increase in respiratory disease mortality hazard ratio......" was deleted

 

 

Reviewer 2 Report

Please find my comments on the attached file.

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop